Cardiotoxicity of anticancer treatments

@article{Ewer2015CardiotoxicityOA,
  title={Cardiotoxicity of anticancer treatments},
  author={M. Ewer and S. Ewer},
  journal={Nature Reviews Cardiology},
  year={2015},
  volume={12},
  pages={547-558}
}
Patients with cancer can experience adverse cardiovascular events secondary to the malignant process itself or its treatment. Patients with cancer might also have underlying cardiovascular illness, the consequences of which are often exacerbated by the stress of the tumour growth or its treatment. With the advent of new treatments and subsequent prolonged survival time, late effects of cancer treatment can become clinically evident decades after completion of therapy. The heart's extensive… Expand
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
Possible Susceptibility Genes for Intervention against Chemotherapy-Induced Cardiotoxicity
Cardiovascular disease in survivors of childhood cancer
Hypertension management in cardio-oncology
Heart Failure and Cancer: Mechanisms of Old and New Cardiotoxic Drugs in Cancer Patients
Breast cancer treatment-induced cardiotoxicity
Cardiac toxicities of anticancer treatments: chemotherapy, targeted therapy and immunotherapy.
Cardio-oncology: an overview on outpatient management and future developments
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 125 REFERENCES
Cardiac Complications of Chemotherapy: Role of Biomarkers
Radiation-associated cardiovascular disease.
Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity.
  • M. Ewer, S. Lippman
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2005
...
1
2
3
4
5
...